Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2318]

Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast...

Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA

Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients ( Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA )

High-dose ifosfamide standard of care for recurrent and primary refractory...

Dr Martin McCabe - University of Manchester, Manchester, England

$High-dose ifosfamide standard of care for recurrent and primary refractory ewing sarcoma ( Dr Martin McCabe - University of Manchester, Manchester, England )$

Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3...

Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA

Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial ( Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA )

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair...

Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer ( Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York )

Review: Best options in localised prostate cancer

Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim...

Review: Best options in localised prostate cancer ( Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim Fizazi )

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle...

Dr Michael Wang - MD Anderson Cancer Center, Houston, USA

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma ( Dr Michael Wang - MD Anderson Cancer Center, Houston, USA )

Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A...

Dr Prateek Jain - Tata Medical Center, Kolkata, India

Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients ( Dr Prateek Jain - Tata Medical Center, Kolkata, India )

COMy 2022: Multiple myeloma roundup

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

COMy 2022: Multiple myeloma roundup ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )

Giving abatacept after checkpoint inhibitors can improve immunotherapy...

Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA

Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma ( Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA )

Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2...

Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA

Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100 ( Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA )

Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for...

Prof Nicolas Girard - Institut Curie, Paris, France

Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for resectable NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

War in Ukraine: Impacts on the Polish cancer care system and vaccination...

Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland

War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges ( Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland )

More from ecancer